Research map: Application of mRNA vaccines in head and neck cancer immunotherapy: Current progress and challenges
Back to the article
Papers in this map
- mRNA vaccine for cancer immunotherapy · Lei Miao · 2021 · 944 citations · Cited by this paper
- TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · 2026 · Related
- Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma · Naoya Kitamura · 2020 · 260 citations · Cited by this paper
- mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics · 2025 · Related
- Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update · Aarti Khushal Bhatia · 2023 · 231 citations · Cited by this paper
- Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · 2026 · Related
- RNA-Based Vaccines in Cancer Immunotherapy · Megan Ann McNamara · 2015 · 221 citations · Cited by this paper
- Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · 2026 · Related
- In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy · Yue Yin · 2021 · 196 citations · Cited by this paper
- The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · 2026 · Related
- Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation · Anne-Line Coolen · 2018 · 194 citations · Cited by this paper
- Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · 2026 · Related
- Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer · Patrick Johannes Schuler · 2014 · 151 citations · Cited by this paper
- Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · 2026 · Related
- Immunotherapy for head and neck cancer: Present and future · Morena Fasano · 2022 · 129 citations · Cited by this paper
- Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · 2026 · Related
- Emerging drugs to treat squamous cell carcinomas of the head and neck · Christopher Fung · 2010 · 110 citations · Cited by this paper
- Cancer vaccines: advances, hurdles, and future directions · 2025 · Related
- Radioimmunotherapy for the treatment of head and neck cancer · Sana D. Karam · 2019 · 108 citations · Cited by this paper
- A real-world study of the effectiveness and safety of low-dose immunotherapy in addition to oral metronomic chemotherapy in recurrent and metastatic head and neck squamous cell carcinoma · 2026 · Related
- Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines · Zhe Sun · 2021 · 99 citations · Cited by this paper
- Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer · Matthew P. Morrow · 2013 · 64 citations · Cited by this paper
- Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines · Junyan Li · 2022 · 62 citations · Cited by this paper
- Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy · Shaolong Qi · 2024 · 62 citations · Cited by this paper
- Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma · Chenhang Yu · 2022 · 52 citations · Cited by this paper
- Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies · Jonathan Cruz Moreira · 2017 · 43 citations · Cited by this paper
- The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy · Marcos Paulo S. Damasio · 2022 · 43 citations · Cited by this paper
- Advances and challenges in immunotherapy in head and neck cancer · Hazem Aboaid · 2025 · 43 citations · Cited by this paper
- Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology · Eden Mariam Jacob · 2024 · 38 citations · Cited by this paper
- Grants supporting research in China · Chunsong Hu · 2018 · 36 citations · Cited by this paper
- Combining Radiotherapy and Immunotherapy in Head and Neck Cancer · Juliana Runnels · 2023 · 36 citations · Cited by this paper
- Advances and prospects of mRNA vaccines in cancer immunotherapy · Yixuan Liu · 2024 · 33 citations · Cited by this paper
- Path towards mRNA delivery for cancer immunotherapy from bench to bedside · Wenfei Chen · 2023 · 30 citations · Cited by this paper
- Precision Cancer Immunotherapy · Takuya Osada · 2015 · 27 citations · Cited by this paper
- Leveraging mRNA technology for antigen based immuno-oncology therapies · Charalampos S. Floudas · 2025 · 26 citations · Cited by this paper
- Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials · Joline Ingels · 2021 · 24 citations · Cited by this paper
- The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers · Sarra Mestiri · 2024 · 24 citations · Cited by this paper
- Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade · Blake R. Heath · 2019 · 23 citations · Cited by this paper
- Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases · Yihan Lu · 2025 · 23 citations · Cited by this paper
Source: OpenAlex (CC0)